SCOPUS 정보 검색 플랫폼

Volumn 58, Issue 11, 2009, Pages 2427-2428

Insulin glargine controversy: A tribute to the editorial team at Diabetologia

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; METFORMIN;

CANCER INCIDENCE; CANCER RISK; CLINICAL PRACTICE; DIABETES MELLITUS; EDITORIAL; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL;

DIABETES MELLITUS; EDITORIAL POLICIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; NEOPLASMS; PERIODICALS AS TOPIC; RISK FACTORS;

EID: 70350525198 PISSN: 00121797 EISSN: 1939327X Source Type: Journal
DOI: 10.2337/db09-9030 Document Type: Editorial

Times cited : (8)

References (9)

1
- 68449104156
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study
- Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW, Sawicki PT. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009;52:1732-1744
- (2009) Diabetologia , vol.52 , pp. 1732-1744
- Hemkens, L.G.¹ Grouven, U.² Bender, R.³ Günster, C.⁴ Gutschmidt, S.⁵ Selke, G.W.⁶ Sawicki, P.T.⁷

2
- 68449104625
- Insulin glargine use and short-term incidence of malignancies - A population-based follow-up study in Sweden
- Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjörnsdò ttir S, Steineck G. Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden. Diabetologia 2009;52:1745-1754
- (2009) Diabetologia , vol.52 , pp. 1745-1754
- Jonasson, J.M.¹ Ljung, R.² Talbäck, M.³ Haglund, B.⁴ Gudbjörnsdò ttir, S.⁵ Steineck, G.⁶

4
- 68449094325
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009;52:1766-1777
- (2009) Diabetologia , vol.52 , pp. 1766-1777
- Currie, C.J.¹ Poole, C.D.² Gale, E.A.³

5
- 68449088664
- Does diabetes therapy influence the risk of cancer?
- Smith U, Gale EA. Does diabetes therapy influence the risk of cancer? Diabetologia 2009;52:1699-1708
- (2009) Diabetologia , vol.52 , pp. 1699-1708
- Smith, U.¹ Gale, E.A.²

6
- 68349148204
- Insulin glargine and malignancy: An unwarranted alarm
- Pocock SJ, Smeeth L. Insulin glargine and malignancy: an unwarranted alarm. Lancet 2009;374:511-513
- (2009) Lancet , vol.374 , pp. 511-513
- Pocock, S.J.¹ Smeeth, L.²

7
- 69949174459
- Insulin glargine and cancer-an unsubstantiated allegation
- Garg SK, Hirsch IB, Skyler JS. Insulin glargine and cancer-an unsubstantiated allegation. Diabetes Technol Ther 2009;11:473-476
- (2009) Diabetes Technol Ther , vol.11 , pp. 473-476
- Garg, S.K.¹ Hirsch, I.B.² Skyler, J.S.³

8
- 67650945180
- Antidiabetic therapies affect risk of pancreatic cancer
- Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009;137:482-488
- (2009) Gastroenterology , vol.137 , pp. 482-488
- Li, D.¹ Yeung, S.C.² Hassan, M.M.³ Konopleva, M.⁴ Abbruzzese, J.L.⁵

9
- 0035082644
- Prevention of pancreatic cancer induction in hamsters by metformin
- Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001;120:1263-1270 (Pubitemid 32246678)
- (2001) Gastroenterology , vol.120 , Issue.5 , pp. 1263-1270
- Schneider, M.B.¹ Matsuzaki, H.² Haorah, J.³ Ulrich, A.⁴ Standop, J.⁵ Ding, X.-Z.⁶ Adrian, T.E.⁷ Pour, P.M.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.